Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shoichiro Mukai
Observed names:
Mukai, Shoichiro,
S. Mukai,
SHOICHIRO MUKAI,
Shoichirou Mukai,
向井, 正一朗
Institution:
University of Miyazaki
Observed institutions:
University of Miyazaki,
Oita Prefectural Hospital,
University of Miyazaki Hospital,
Yoshida General Hospital
ORCID:
0000-0002-1678-8619
Observed ORCID:
0000-0002-1678-8619
OpenAlex ID:
A5082923461
Works
82
Awards
3
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
2025
·
Maria De Santis
, Joan Palou Redorta
, et al.
·
The Lancet
·
106
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
2007
·
Hironori Betsunoh
, Shoichiro Mukai
, et al.
·
Cancer Science
·
86
Activation of hepatocyte growth factor activator zymogen (pro‐HGFA) by human kallikrein 1‐related peptidases
2008
·
Shoichiro Mukai
, Tsuyoshi Fukushima
, et al.
·
FEBS Journal
·
68
PDF
Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis
2014
·
Shoichiro Mukai
, Kenji Yorita
, et al.
·
Human Cell
·
48
PDF
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
2021
·
Takashi Kobayashi
, Katsuhiro Ito
, et al.
·
Cancer Immunology Immunotherapy
·
39
Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
2015
·
Satoru Sugie
, Shoichiro Mukai
, et al.
·
PubMed
·
32
Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers
2020
·
Shoichiro Mukai
, Koji Yamasaki
, et al.
·
International Journal of Molecular Sciences
·
31
PDF
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors
2022
·
Wataru Fukuokaya
, Takahiro Kimura
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
27
Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis
2018
·
Koji Yamasaki
, Shoichiro Mukai
, et al.
·
International Journal of Molecular Sciences
·
26
PDF
Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men.
2013
·
Satoru Sugie
, Shoichiro Mukai
, et al.
·
PubMed
·
24
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
2019
·
Naoki Terada
, Toshiyuki Kamoto
, et al.
·
BMC Cancer
·
22
PDF
Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis
2015
·
Shoichiro Mukai
, Kenji Yorita
, et al.
·
Human Cell
·
21
Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer
2018
·
Toyoharu Kamibeppu
, Koji Yamasaki
, et al.
·
Research and Reports in Urology
·
20
PDF
Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression
2015
·
Satoru Sugie
, Shoichiro Mukai
, et al.
·
Human Cell
·
18
Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias
2022
·
Hikari Otsuka
, Yuki Kita
, et al.
·
Cancer Science
·
15
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching
2021
·
Naotaka Nishiyama
, Takashi Kobayashi
, et al.
·
Journal of Geriatric Oncology
·
13
Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations
2019
·
Takayuki Goto
, Takahiro Inoue
, et al.
·
International Journal of Clinical Oncology
·
13
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
2023
·
Masaki Shiota
, Hideaki Miyake
, et al.
·
Cancer Immunology Immunotherapy
·
12
Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells
2021
·
Junsuke Uwada
, Shoichiro Mukai
, et al.
·
Life Sciences
·
12
Myopericytoma in urinary bladder: a case report
2017
·
Takahiro Nagai
, Toshio Kamimura
, et al.
·
Journal of Medical Case Reports
·
12
PDF
A Case of Bladder Pheochromocytoma
2001
·
Narihito Seki
, Shoichiro Mukai
, et al.
·
Urologia Internationalis
·
12
Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men
2013
·
Satoru Sugie
, Hiromasa Tsukino
, et al.
·
Tumor Biology
·
11
PER3 polymorphisms and their association with prostate cancer risk in Japanese men
2020
·
Hinoura, Takuji
, Mukai, Shoichiro
, et al.
·
Journal of preventive medicine and hygiene
·
10
PDF
Effect of dutasteride on microvessel density in benign prostatic hyperplasia.
2014
·
Satoru Sugie
, Shoichiro Mukai
, et al.
·
PubMed
·
10
Functional polymorphism in the CAV1 T29107A gene and its association with prostate cancer risk among Japanese men.
2013
·
Satoru Sugie
, Hiromasa Tsukino
, et al.
·
PubMed
·
9
Show more works
View as search
Works count:
82
Citation count:
821
H-index:
15
I10-index:
24
Year
Topic
Type